For the breast cancer therapeutic target ERα, the required data were obtained from the University of Alberta’s DrugBank database of drug molecules, which is a unique bioinformatics and cheminformatics resource that combines detailed drug data with comprehensive drug target information for the study of drug mechanisms and even the exploration of novel drugs. This evidence concerns the gene ESR1 and breast carcinoma.